与特拉佐相关的口腔动障碍症
1Department of Psychiatry, Keck School of Medicine, University of Southern California, Newport Beach, CA, United States.
Journal of family medicine and primary care
|May 13, 2024
概括
特拉佐可以在使用几个月后引起口腔语言动力障碍,一种运动障碍. 在所有报告的病例中,停止使用特拉佐 (一种药物) 导致这些症状立即消失.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 运动障碍 运动障碍
背景情况:
- 特拉佐是一种抗抑郁药物.
- 口腔语言动力障碍是影响舌头和嘴巴的非自愿运动.
- 药物诱导的运动障碍在临床实践中是一个重大问题.
研究的目的:
- 报告三例特拉佐诱导的口腔语言运动障碍病例.
- 探索特拉佐在引起和潜在治疗运动障碍方面的作用的潜在机制.
- 为了突出与特拉佐相关的老年人中 dystonic 运动的患病率.
主要方法:
- 关于三名患有口腔语言功能障碍的患者的案例系列报告.
- 详细的患者病史,包括特拉佐暴露的持续时间和之前的药物使用 (多巴胺阻断剂).
- 在停止使用特拉佐后观察症状变化.
主要成果:
- 鉴定出了三种特异性的特拉佐诱导的口腔语言动力障碍病例.
- 几个月的特拉佐暴露后出现的症状.
- 所有病例在停止治疗后突然消失.
- 两名患者以前没有接触过多巴胺阻断剂;一个人有遥远的病史.
结论:
- 特拉佐可以诱导口腔语言功能障碍.
- 特拉佐的作用机制可以解释这些运动的发展和解决.
- 对特拉佐的神经药理学影响的进一步研究是有必要的,特别是对于老年患者和 dystonic 运动.
更多相关视频
相关概念视频
Parkinson's Disease: Treatment
263
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
263
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
309
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
309
Sedatives and Hypnotics Drugs: Miscellaneous Agents
170
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
170
Antidepressant Drugs: MAOIs and Other Agents
226
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
226
Skeletal Muscle Relaxants: Adverse Effects
358
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
358
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
268
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
268


